ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | -50.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | -33.3% | 2,000 | -39.4% | 0.00% | – |
| Q2 2016 | $6,000 | -14.3% | 3,299 | -1.5% | 0.00% | – |
| Q1 2016 | $7,000 | +16.7% | 3,350 | +1.4% | 0.00% | – |
| Q4 2015 | $6,000 | -33.3% | 3,303 | -35.3% | 0.00% | – |
| Q3 2015 | $9,000 | -65.4% | 5,103 | -8.2% | 0.00% | – |
| Q2 2015 | $26,000 | +18.2% | 5,560 | +11.6% | 0.00% | – |
| Q1 2015 | $22,000 | +83.3% | 4,984 | +43.1% | 0.00% | – |
| Q4 2014 | $12,000 | -20.0% | 3,484 | 0.0% | 0.00% | – |
| Q3 2014 | $15,000 | -82.6% | 3,484 | -76.6% | 0.00% | – |
| Q2 2014 | $86,000 | -8.5% | 14,884 | 0.0% | 0.00% | – |
| Q1 2014 | $94,000 | -5.1% | 14,884 | -11.9% | 0.00% | – |
| Q4 2013 | $99,000 | +19.3% | 16,900 | +6.3% | 0.00% | – |
| Q3 2013 | $83,000 | -24.5% | 15,900 | +11.2% | 0.00% | – |
| Q2 2013 | $110,000 | – | 14,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |